ASCENTAGE PHARMA GROUP INTERNATIONAL - AAPG

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$1.248M
QoQ value delta ($000)
-$1.733M (-58.13%)
Implied price effect (QoQ)
-33.27%
Shares
Total shares
47,770
QoQ shares delta
-28,376 (-37.27%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (AAPG)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q2 2026 data: only 8 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
Point72 Asset Management, L.P. 438 16,726 0.0%
XY Capital Ltd 357 13,628 0.22%
CITADEL ADVISORS LLC 255 9,737 0.0%
UBS Group AG 111 4,232 0.0%
Mirae Asset Global Investments Co., Ltd. 66 2,546 0.0%
Tower Research Capital LLC (TRC) 6 230 0.0%
BANK OF AMERICA CORP /DE/ 5 201 0.0%
OSAIC HOLDINGS, INC. 5 220 0.0%
MORGAN STANLEY 4 153 0.0%
Bell Investment Advisors, Inc 1 67 0.0%
ROYAL BANK OF CANADA 0 6 0.0%
EverSource Wealth Advisors, LLC 0 24 0.0%